IDEAYA Biosciences (IDYA) Misses Q4 EPS by 5c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.52), $0.05 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $8.84 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• DHT Holdings Q2 TCE earnings estimated at $126,700 per day
• Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy